Recent healthcare provider news you may have missed

Recent healthcare provider news you may have missed

From Christine Williamson, Vice President at Greenough Brand Storytellers

Sweeping Changes to Massachusetts Healthcare Laws

Governor Baker’s healthcare proposal is ambitious and all-encompassing. The Boston Globe writes: “It takes the unusual step of requiring hospitals and insurers to increase their spending on primary care and behavioral health care by 30 percent over three years. In order to do this and meet existing requirements to control health spending, they will need to scale back in other areas — such as expensive hospital services.”

For more information, check out The Boston Globe

———

States Prepare Health Insurance Contingency Plans

A federal appeals court decision that could strike down the Affordable Care Act could come as soon as this month! See how lawmakers in states including Louisiana, Nevada, New Mexico and California are pursuing legislation to preserve some healthcare coverage if the ACA is overturned.

Read story in The Wall Street Journal to learn more about what’s at stake

———

Is a Harsh Flu Season a Boom or a Bust for Providers?

A severe flu season can impact providers’ bottom lines in many ways. According to Healthcare Dive, large, publicly traded health systems can see a slight boost to margins despite the additional staffing needed to combat flu, but smaller and nonprofit organizations are more strained and have less ability to capitalize on increased visits. Read on to see the impact to community hospitals, telehealth companies, urgent care and skilled nursing facilities.

Get the full story at Healthcare Dive

———

Health Insurers Tackle Social Determinants of Health

Jeffrey Brenner, a physician turned health insurance executive, aims to reduce healthcare expenses not by denying care, but by spending more on social interventions, starting with housing. But how to do it is still largely uncharted.

Dive deeper with Bloomberg

Week of November 4, 2019

Healthcare/Life Sciences

 Mission-based

 

 

Consumer

 

 Technology

 

Recent medtech stories you may have missed

Recent medtech stories you may have missed

From Rachel RobbinsSenior Vice President at Greenough Brand Storytellers

Artificial intelligence and robotics top trends that will transform healthcare in 2020

From the use of machine learning to process enormous amounts of medical data to robotics that span surgical use, transporting medical supplies and helping patients with rehab, technology will continue to transform healthcare in 2020. According to this Forbes article, wearable tech, 3D printing and extended reality (virtual, augmented and mixed) also show incredible promise for patients and medical professionals. In fact, a team of scientists at Rensselaer Polytechnic Institute in New York has developed a way to 3D print living skin, complete with blood vessels.

 

Competition heats up in robot-assisted surgery market

Robotic-assisted surgery using da Vinci robots – which enable surgeons to perform delicate and complex operations through a few small incisions – continue to skyrocket. This is evident through Intuitive Surgical’s latest sales numbers, bringing the total number of da Vinci systems in operation to more than 5,400 worldwide. Despite this domination, only about 2% of surgeries worldwide are performed using robotic surgery equipment. The competition is about to heat up, with medical device giant Medtronic planning to launch its Hugo system in 2020—a system they claim is more flexible and cost-effective than those presently on the market.

 

More Americans using wearable fitness trackers to monitor health than ever before

Millions of Americans are using technology to monitor their exercise, heart rate, calorie consumption, sleep quality and step count. According to ACSM’s survey of 2020 fitness trends, the use of wearable technology—now a $95 billion industry—topped the list for the third year in a row. Google is tapping into the success of the fitness tracker market, going head-to-head with Apple and Samsung, announcing last week it is buying Fitbit for $2.1 billion. The purchase will help Google tap into an enormous amount of health data, with more than 28 million users on the Fitbit platform.

 

New technology promises to change the future of cancer diagnosis and treatment

In conjunction with Lung Cancer Awareness Month, Auris Health unveiled a revolutionary robot that can detect lung cancer at an early stage. Data from the company’s first study on live human subjects show its Monarch robotic system can successfully target hard-to-reach lung nodules and obtain a tissue sample for biopsy. The robot is a promising advancement that has the potential to change the future of cancer diagnosis and treatment. Similarly, Thermo Fisher Scientific unveiled its Ion Torrent Genexus System this week—a next-generation sequencing (NGS) platform that can deliver results in a single day, which will enable patients to be matched to targeted therapies or clinical trials faster. The system simplifies genomic testing so it can be performed in any clinical setting – including community hospitals, where most cancer patients are treated today.

 

Press Release: Agencies Align Life Science/Healthcare Expertise to Offer Integrated Marketing Services on Both Sides of the Pond

Press Release: Agencies Align Life Science/Healthcare Expertise to Offer Integrated Marketing Services on Both Sides of the Pond

Greenough Brand Storytellers and kdm communications share best practices and systems to jointly serve clients expanding into U.S. or from U.S. into Europe

November 6, 2019 – Greenough Brand Storytellers and kdm communications, two well-established independent PR agencies with strong life sciences and healthcare operations in their respective regions, will now combine forces to better serve clients expanding their marketing activities across global markets.

Together, Greenough and kdm form a dynamic team of more than 50 people (including 15 scientists) who bring unique insights to stories for life sciences and healthcare audiences across major business markets globally. This ensures that cultural, language, regulatory, policy and other local challenges, including time zone differences, will never stand in the way of successful campaign strategy and execution.

The agencies will share best practices and systems in response to increasing client demand for scientific writing, video production, globally managed product launches and multilingual thought leadership campaigns.

“Many of our respective clients are global companies with opportunities all over the world, and we value a partner across the pond in the U.S. who not only understands the landscape there, but also can help us shape creative global campaigns,” said Annabel Sedgwick, managing director, kdm communications. “We have found that partner in Greenough and look forward to working together to deliver integrated campaigns for key markets worldwide.”

“Many of our clients have already benefitted from having kdm’s complementary scientific and marketing expertise readily available, and we can bring this value to others, including clients we approach jointly,” said Scott Bauman, EVP, GM, Greenough Brand Storytellers. “Beyond the obvious time savings for translation and other functions, our teams benefit from pushing each other creatively, something we’ll be doing more of in the coming year as part of our strategy to enable more globally integrated campaigns.” 

About kdm communications

kdm communications Ltd is an award-winning specialist scientific marketing agency offering creative design and compelling content that deliver world-class outcomes for our clients. With twelve scientists in house and decades of marketing experience, kdm offers its clients a unique blend of PhD-level scientific understanding with strategic and tactical marketing expertise. Located in Cambridge, UK, we consider ourselves to be Europe’s go-to scientific marketing agency based on our in-house linguistics skills, global reach and technical understanding. And we eat a lot of cake.

To find out more visit www.kdm-communications.com or contact anna@kdm-communications.com

About Greenough Brand Storytellers

Greenough Brand Storytellers builds brands through the power of storytelling and is nationally recognized for its award-winning public relations, social media and integrated marketing programs. Since 1999, Greenough has helped companies develop and implement marketing and communication programs that drive awareness, generate conversations and deliver qualified leads. For more information, visit http://www.greenough.biz or read our blog at http://www.greenough.biz/blog.

Recent life science news bites you may have missed

Recent life science news bites you may have missed

From Jen Heady, Vice President at Greenough Brand Storytellers

———————–

Prime editing takes the spotlight

Just six years after Feng Zhang and George Church first harnessed the power of CRISPR-Cas9 for genome editing, WIRED magazine has already coined the term “classic CRISPR” to describe this now widely referenced genome editing approach. The term “classic” differentiates CRISPR-Cas9 from a hot new CRISPR technique: prime editing. While critics say prime editing may be less practical than existing methods, the number of new genome editing techniques and studies introduced over the last several years is a testament to the incredibly fast progression of science.

Read Megan Molteni’s coverage in WIRED

Check out the Broad Institute’s handy infographic explaining the prime editing process

For a history of CRISPR, visit the Broad Institute’s CRISPR timeline

———————–

VC funding: It’s all about who you know

In her latest for STAT, Kate Sheridan covers how venture capital’s reliance on relationships is contributing to gender, racial and geographic disparities in the biotech space. What can be done to increase diversity? For entrepreneurs, the answer may be as simple as engaging with venture capitalists outside of your own network before launching a company. Bottom line: it’s still about who you know, but don’t limit your network to those in your current circle.

Read the full story

https://www.statnews.com/2019/10/31/social-connections-first-science-second/

———————–

Inside scoop: A former Biogen employee on the company’s “shocking” Alzheimer’s news

Biogen made big headlines by announcing that it will submit aducanumab for FDA approval after halting a study on the Alzheimer’s drug earlier this year. Since the news dropped, journalists, Wall Street analysts and experts have speculated on how the company could have reinterpreted the data so drastically. As a former Biogen employee who “worked on and around aducanumab,” Ted Whitford writes that Biogen hasn’t been afraid to admit failures in the past, and that he hopes the company made a mistake in its earlier analysis. “But if it didn’t,” writes Whitford, “and this is another example of the American public watching big pharma trying to spin bad data, then I can’t help but wonder if Biogen, and perhaps the industry has lost its way.” One thing is certain: all eyes will be on Biogen next time it announces data on the buzzworthy drug. 

Read Ted Whitford’s “First Opinion” piece for STAT

 

Week of October 14, 2019

Healthcare/Life Sciences

 

 

 

Professional Services

 

 

 

 Mission-based

 

 

 

  Technology